Rethinking Strategy: Moving Beyond Disease Stage with AI-Enabled Translational & Retrospective Drug Development
- Challenge traditional disease stage–focused development by adopting strategies that transcend indication silos
- Explore how AI can act as a disruptive enabler to reimagine how translational data is collected, integrated, and applied
- Demonstrate how these combined approaches can retrospectively inform new molecule design and accelerate the next generation of therapies